Our study further validated our previous investigation of PI3K/AKT signaling in SCLC therapeutic resistance [7] and revealed the connection between PI3K/AKT/mTOR signaling and the PPP underlying SCLC radioresistance. This evidence concerns the gene MTOR and small cell lung carcinoma.